Pangaea Oncology SA Sustainability Reports

Pangaea Oncology, S.A. operates as a medical services and translational precision oncology company that integrates molecular diagnostics, preclinical modeling, and clinical research to optimize cancer therapies.

Sector: Healthcare & social services

Country: Spain

Exchange: Bolsa de Madrid (BME)

LEI: 959800TSRNQZYHX37Y29

FIGI: BBG00FN9QP16

10 reports from 2014 to 2025

• Pangaea Oncology SA 2025 To the BME Growth Segment of BME MTF Equity
• Pangaea Oncology SA 2024 Other Relevant Information
• Pangaea Oncology SA 2023 Annual Accounts and Management Report
• Pangaea Oncology SA 2023 Information Document on Organizational Structure and Internal Control Systems
• Pangaea Oncology SA 2020 Full-Year Results Presentation